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 Idiopathic granulomatous mastitis (IGM) is a chronic inflammatory condition that may cause diagnostic difficulties during 
clinical tests and radiological examinations in terms of differentiation from contagious diseases, such as tuberculosis 
(TB) and fungal infections, as well as cancer. This report presents the case of a 23-year-old woman with granulomatous 
mastitis, along with a discussion of the diagnostic dilemmas based on a clinical test, mammography, ultrasonography 
and histopathological examination. IGM produces varied and non-specific manifestations on mammography and ultra-
sonography. Therefore, histopathological examination is necessary to make an unambiguous diagnosis. The possibility of 
this condition must always be borne in mind to minimise the risk of an erroneous cancer diagnosis. There are no standard 
procedures in force for the treatment of IGM. 
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Introduction
IGM is a rare, benign and chronic inflammatory condition of the 
breasts, which affects women of childbearing age [1, 2]. The 
first description of the disease was presented in 1972 by Kes-
sler et al. to define granulomatous mastitis with an unknown 
etiological agent [3]. In 1987, Going et al. recommended the 
term ‘granulomatous lobular mastitis’ (GLM) to differentiate the 
lesion from granulomatous periductal mastitis [4]. The lesion 
was described as granulomatous mastitis affecting the breast 
lobule and leading to its destruction. The granulomas were 
made up of histiocytes, Langhans giant cells, lymphocytes and 
plasmacytes. Granulomas do not undergo caseous necrosis. 
Over time, the lesions may form confluent structures with 
fat tissue necrosis, abscess formation and fibrosis. Selective 
tests fail to reveal any microorganisms and the lesions con-
tain no foreign bodies. Occasionally, it is possible to observe 
focal lesions related to lactation in women who have recen-
tly been pregnant. Differential diagnostics also encompass 
other granulomatous lesions. Differentially diagnosing with 
tuberculosis, sarcoidosis and cat-scratch disease (CSD) is most 
often performed on the basis of clinical and histopathologi-
cal images [5,6]. This process must always take into account 
granulomatous mastitis, which accompanies infiltrating or in 
situ breast cancer [7, 8].  
Case report
A 23-year-old female patient reported to the Oncological 
Surgery Outpatient Clinic due to a tumour in the left breast, 
which she had discovered about 1.5 months earlier. No other 
present or past diseases were reported during history taking. 
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No cancer cells were found on fine-needle aspiration biop-
sy (FNAB) of the lymph nodes.
Seven days after CNB, numerous hard, erythematous and 
suppurative foci appeared over the tumour (Fig. 4).
Swabs were taken from the lesions, but the bacterial cul-
tures from the skin and the purulent secretion for Actinomyces 
and Nocardia were negative. 
Since the clinical picture might have suggested actinomy-
cosis, a pathologist was asked to search for the characteristic 
“sulphuric granules”. The specimen was therefore dissected and 
thoroughly examined again. Unfortunately, the histopathologi-
cal examination of numerous samples stained with hematoxylin 
and eosin did not confirm the presence of “sulphuric granules” 
or filamentous bacteria. In order to confirm or finally exclude an 
Actinomyces israeli infection, the Gram staining technique was 
used, yet did not confirm the presence of Gram-positive bacteria. 
Fungal infection was also excluded based on an assessment 
of Grocott-stained specimen samples. Ziehl-Neelsen staining, 
which was performed on mycobacteria, yielded a negative 
result. The granulomas revealed no presence of the caseous 
necrosis typical of TB. Since an etiological factor was not found, 
the case in question was assumed to be granulomatous mastitis.
The patient was started on oral Amoxicillin at a dose of 1g 
twice a day, for the first month. Next, the therapy was reduced 
to 1g once a day. After six months of the therapy, the tumour 
was no longer palpable, the skin lesions had decreased and the 
filtration subsided. After the following three months, the skin 
lesions disappeared. The patient remains under observation. 
Three years earlier, she had given  birth naturally to one child 
and breast-fed for six months. The patient reported no family 
history of cancers, and did not suffer from fever, lung diseases, 
dental problems, facial skin lesions, tonsillitis, gingivitis or bre-
ast injuries. Physical examination of the left breast, within the 
external quadrants, revealed a palpable tumour of 8 x 8 cm 
in diameter, which was hard and rough, poorly mobile, and 
produced no lesions on the skin above it. In the left axillary 
fossa, there were single enlarged and mobile lymph nodes. 
Clinically, the lesion aroused suspicion of a cancerous growth.
A blood test revealed mild leukocytosis (white blood cell 
[WBC] count: 10 100) and increased C-reactive protein con-
centration (176 mg/l, <10 mg/l). No abnormalities were shown 
in the patient’s chest X-ray.
A breast X-ray revealed an area of irregular structure in 
the external quadrants on the left side, measuring 8 x 8 cm, 
with strong local vascularisation and local micro-calcifications 
(BIRADS-5). In the bottom and middle parts of the left axilla 
(armpit), there were four completely hypoechogenic lymph 
nodes and one with a cortex thickened to 6 mm. These were 
U4-type nodes (Fig. 1).
Contrast-enhanced spectral mammography revealed 
a non-homogeneous, irregular infiltration measuring 11 x 6 cm 
in the left breast and abnormal lymph nodes of 10 mm in short-
-axis view in the left axillary fossa. The right breast showed no 
radiologically suspicious changes (BIRADS-5) (Fig. 2).
An ultrasound-guided core-needle biopsy (CNB) was per-
formed. The histopathological examination of the specimen 
revealed severe, chronic active breast inflammation (mastitis). 
The connective tissue stroma showed the presence of tiny 
necrotic foci. The entire specimen contained numerous visible 
inflammatory granulomas made up of epithelioid cells, mainly 
multinucleate giant cells. No necrosis was found in any of the 
granulomas. Minor reactive lesions were observed within the 
ductal epithelium. A cytokeratin (CK) immunohistochemical 
study was performed to confirm the presence of potential can-
cer infiltration cells. However, the result of this study excluded 
the presence of cancer cells in the specimen (Fig. 3).
Figure 1. Ultrasonography of the left breast
Figure 2. Spectral mammography of the left breast
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Discussion
Idiopathic granulomatous mastitis is a rare, chronic inflamma-
tory condition of the breasts, primarily observed in women of 
childbearing age. Its precise etiology is not known. One hypo-
thesis is that it is caused by autoimmune factors or associated 
with lactation [9, 10].
The dominant feature is most commonly a tumour, usually 
with a cohesive texture, which may be accompanied by pain, 
reddening and enlarged lymph nodes [10]. As the disease 
progresses, there are other manifestations such as pulled-in 
nipples, reddening, ulceration and fistulas, which may lead 
to erroneous diagnoses of infiltrating breast cancer [11, 12].
Imaging examinations of IGM, such as mammography and 
ultrasonography, are non-specific and may often be mistakenly 
interpreted as cancer. In the case at hand, the tumour lesion in 
the breast was classified as BIRADS-5 on both mammography 
X-ray and ultrasonography. Some authors suggest performing 
magnetic resonance imaging (MRI) in IGM diagnostics. Ho-
wever, studies have revealed that MRI provides no additional 
data helpful in differentiating between IGM and breast cancer.
Due to the ambiguous IGM assessments from clinical and 
imaging examinations, diagnosis should be based on a histo-
pathological analysis following CNB or tumorectomy [4, 11, 
12]. Besides infiltrating cancer, differential diagnostics should 
also take into consideration other chronic inflammatory breast 
conditions, such as plasma cell inflammation, histoplasmosis, 
tuberculosis and Wegener’s granulomatosis [13].
The treatment of idiopathic granulomatous mastitis is 
diverse, and the therapeutic options include conservative 
treatment with an antibiotic, corticosteroid therapy or wide 
local excision (WLE). A study by Atak et al. revealed that the best 
treatment method for IGM patients involved surgical excision 
combined with the administration of steroids [14].
Similarly, in a study by Sheybani et al. conducted on twen-
ty-two IGM patients, surgical treatment was the treatment of 
choice [15]. In a study by Mahmodlou et al., steroid therapy as 
a therapeutic method was found to be an effective treatment 
method for IGM as it reduced inflammation [16]. Our patient 
was started on antibiotic therapy for six months, resulting in 
withdrawal of the symptoms.
The condition produces varied and non-specific mani-
festations on mammography and ultrasonography. Histo-
pathological examination is therefore necessary to make 
a diagnosis. However, the possibility of IGM must always be 
borne in mind to minimise the risk of an erroneous cancer 
diagnosis. There are no standard procedures in force for the 
treatment of IGM. 
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Figure 3. Mixed lympho-granulocytic inflammatory infiltrate with non-necrotic granuloma (A). Non-necrotic granuloma with multinucleate giant cells 
(the black arrow) and a breast lobule (the white arrow), HE, magn. 100x (B)
A B
Figure 4. The left breast 7 days after CNB
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